eli lilly glp 1 drug Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds Lilly's Double-Beat Widens the GLP-1

Women with T2DM have a similarly high risk for pregnancy complications as pregnant women with type 1 diabetes...

This process preserves the full molecular spectrum of saffron, including volatile compounds like safranal, which are often lost during conventional extraction methods.Its content is 10 times higher in safranal and 20 times more concentrated in crocins than standard extracts, enhancing the effects of saffron on emotional balance

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

This article explores current clinical evidence, provider decision-making frameworks, and how genetic insights may inform a personalized conversation with your healthcare

This comprehensive review critically evaluates recent advances in BBRs anti-obesity pharmacology through three lenses: (1) preclinical and clinical evidence from randomized controlled trials, (2) molecular mechanisms underlying metabolic regulation, and (3) innovative strategies for pharmacokinetic optimization

GLP-1R agonist 2 has the potential for research in metabolic diseases such as type 2 diabetes and obesity